BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36423688)

  • 1. SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer.
    Ramakrishnan AB; Burby PE; Adiga K; Cadigan KM
    J Biol Chem; 2023 Jan; 299(1):102735. PubMed ID: 36423688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
    Huang BL; Brugger SM; Lyons KM
    J Biol Chem; 2010 Sep; 285(36):27702-12. PubMed ID: 20571031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells.
    Sellak H; Wu S; Lincoln TM
    Biochim Biophys Acta; 2012 Oct; 1823(10):1666-75. PubMed ID: 22766303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
    Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
    J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
    Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
    J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.
    Prévostel C; Rammah-Bouazza C; Trauchessec H; Canterel-Thouennon L; Busson M; Ychou M; Blache P
    Oncotarget; 2016 Dec; 7(50):82228-82243. PubMed ID: 27429045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2.
    Sinha A; Fan VB; Ramakrishnan AB; Engelhardt N; Kennell J; Cadigan KM
    Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
    Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
    Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCFs and Wnt/β-catenin signaling: more than one way to throw the switch.
    Cadigan KM
    Curr Top Dev Biol; 2012; 98():1-34. PubMed ID: 22305157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
    Usongo M; Li X; Farookhi R
    Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction.
    Gan XQ; Wang JY; Xi Y; Wu ZL; Li YP; Li L
    J Cell Biol; 2008 Mar; 180(6):1087-100. PubMed ID: 18347071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
    Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
    Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers.
    Yochum GS; Sherrick CM; Macpartlin M; Goodman RH
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex determining region Y-box 9 induced microtubule formation and epithelial⁃mesenchymal transition in human oral squamous cell carcinoma CAL27 cells.
    Huang S; Zhang QY; He AE; Li HB; Zhang ZX
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):74-80. PubMed ID: 33723940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.